So, in a portion of patients with advanced melanoma, fecal microbiota delivered colonoscopically in combination with anti-PD-1 successfully colonized the responders’ gut and changed the tumor microenvironment, overcoming their initial resistance to anti-PD-1. This evidence concerns the gene PDCD1 and neoplasm.